The University Of Texas Health Science Center At San Antonio

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Empagliflozin and Hepatic Glucose Metabolism

Phase 4

Completed

Conditions: Hepatic Glucose Metabolism

Interventions: Drug: Control
Drug: Empagliflozin 25 MG

First Posted Date: 2017-06-21

Last Posted Date: 2024-08-28

Lead Sponsor: The University of Texas Health Science Center at San Antonio

Target Recruit Count: 72

Registration Number: NCT03193684

Locations: 🇺🇸
Diabetes Division, UTHSCSA, San Antonio, Texas, United States

Ridge Preservation Using FDBA and a Collagen Wound Dressing in Molar Sites

Not Applicable

Completed

Conditions: Tooth Extraction

Interventions: Procedure: Ridge preservation
Device: FDBA
Device: Collagen wound dressing

First Posted Date: 2017-06-19

Last Posted Date: 2018-04-09

Lead Sponsor: The University of Texas Health Science Center at San Antonio

Target Recruit Count: 27

Registration Number: NCT03191448

Effects of Canagliflozin on Intravascular Volume and Hemodynamics

Phase 4

Withdrawn

Conditions: Cardiovascular Diseases
Type2 Diabetes Mellitus

Interventions: Drug: Placebo
Drug: Canagliflozin 300mg

First Posted Date: 2017-06-19

Last Posted Date: 2017-10-12

Lead Sponsor: The University of Texas Health Science Center at San Antonio

Registration Number: NCT03190798

Locations: 🇺🇸
The University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States

PROTOCOL 3: Role of the Renal Nerves in the Increase in EGP in Response to Glucosuria

Phase 4

Completed

Conditions: Diabetes Mellitus, Type 2

Interventions: Drug: Dapagliflozin 10mg then Placebo Oral Tablet
Drug: Placebo Oral Tablet then Dapagliflozin 10mg

First Posted Date: 2017-05-30

Last Posted Date: 2020-09-17

Lead Sponsor: The University of Texas Health Science Center at San Antonio

Target Recruit Count: 34

Registration Number: NCT03168295

Locations: 🇺🇸
The University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States

TRanslesIonal Assessment of Gradients During Endovascular Therapy

Completed

Conditions: Hemodynamics
Fractional Flow Reserve
Peripheral Arterial Disease

First Posted Date: 2017-05-22

Last Posted Date: 2022-02-18

Lead Sponsor: The University of Texas Health Science Center at San Antonio

Target Recruit Count: 22

Registration Number: NCT03163199

Locations: 🇺🇸
University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States

Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions

Recruiting

Conditions: Pheochromocytoma
Paraganglioma
Associated Conditions
Inherited Cancer Syndrome
Kidney Neoplasms
Bone Cancer
Thyroid Neoplasms
Other Cancer

First Posted Date: 2017-05-19

Last Posted Date: 2023-09-26

Lead Sponsor: The University of Texas Health Science Center at San Antonio

Target Recruit Count: 2000

Registration Number: NCT03160274

Locations: 🇺🇸
University of Texas Health Science Center, San Antonio, Texas, United States

Imipramine on ER+ve and Triple Negative Breast Cancer

Early Phase 1

Completed

Conditions: Breast Cancer

Interventions: Drug: Imipramine

First Posted Date: 2017-04-20

Last Posted Date: 2023-06-28

Lead Sponsor: The University of Texas Health Science Center at San Antonio

Target Recruit Count: 17

Registration Number: NCT03122444

Locations: 🇺🇸
Mays Cancer Center, UT Health San Antonio, San Antonio, Texas, United States

Rectal Misoprostol as a Hemostatic Agent During Abdominal Myomectomy

Phase 4

Completed

Conditions: Myomectomy; Surgical Blood Loss

Interventions: Drug: Misoprostol 100Mcg Tab
Drug: Placebo

First Posted Date: 2017-02-27

Last Posted Date: 2024-12-13

Lead Sponsor: The University of Texas Health Science Center at San Antonio

Target Recruit Count: 18

Registration Number: NCT03064568

Locations: 🇺🇸
St. Lukes Baptist Hospital, San Antonio, Texas, United States
🇺🇸
University Hospital, San Antonio, Texas, United States
🇺🇸
University of Texas Health Science Center, San Antonio, Texas, United States

Rapid PCR to Guide Antibiotic Therapy at the Time of Prostate Biopsy

Not Applicable

Completed

Conditions: Antibiotic Therapy
Prostate Biopsy

Interventions: Other: rPCR results
Other: Control group

First Posted Date: 2017-02-01

Last Posted Date: 2020-02-05

Lead Sponsor: The University of Texas Health Science Center at San Antonio

Target Recruit Count: 38

Registration Number: NCT03040050

Locations: 🇺🇸
South Texas Veterans Health Care, San Antonio, Texas, United States

Sorafenib Induced Autophagy Using Hydroxychloroquine in Hepatocellular Cancer

Phase 2

Active, not recruiting

Conditions: Hepatocellular Cancer

Interventions: Drug: Sorafenib (SOR)
Drug: Hydroxychloroquine (HCQ)

First Posted Date: 2017-01-31

Last Posted Date: 2024-08-13

Lead Sponsor: The University of Texas Health Science Center at San Antonio

Target Recruit Count: 64

Registration Number: NCT03037437

Locations: 🇺🇸
University of Texas Health Cancer Center, San Antonio, Texas, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy